In Calgary, Alberta, the Arthur J.E. Child Comprehensive Cancer Center includes a GPO-led clinic that manages patients with breast cancer who are eligible for adjuvant ET plus CDK4/6 inhibitor therapy or adjuvant olaparib. This evidence concerns the gene CDK4 and cancer.